v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04461379 |
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Nov. 14, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
rodriguezgutierrez.rene@mayo.edu |
Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2020-07-08 |
Recruitment status
Last imported at : Nov. 4, 2022, 8 a.m. Source : ClinicalTrials.gov |
Unknown |
Study design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Prevention |
Inclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
inclusion criteria: - health workers who are working onsite in patients' areas with covid-19 - age > 18 years - negative specific igg and igm antibodies test result for sars cov-2 before the enrollment. - provide a signed and dated informed consent form |
Exclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
- age <18 years - positive test for specific antibodies igg and igm antibodies result for sars cov-2 - primary or secondary immunosuppression - use of immunosuppression drugs, use of hydroxychloroquine, cloroquine, azithromycin, lopinavir/ritonavir, ivermectin or any other drug used to treat patients covid-19 before the enrollment. - chemotherapy treatment - presence of antibodies iga, igm, igg against sars-cov-2 - pregnancy or breastfeeding - missing informed consent form - fever > 38° in the previous 24 hours - any bcg vaccine contraindication - history of previous allergy to the components of the vaccine - already part of any other trial - previous or active tuberculosis (tb) disease - another vaccine administrated 4 months before the start of the trial. - any underlying history of malignancy or lymphoma. - actual treatment with steroids - absence of more than 1 month from the hospital, from the study period. |
Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Hospital Universitario Dr. Jose E. Gonzalez |
Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Mexico |
Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Health workers |
Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
N/A |
Total sample size
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
908 |
primary outcome
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Critical care admission with SARS-CoV2;Demonstrate COVID- 19 disease incidence among Health care workers:;Demonstrate cumulative incidence of hospitalization for COVID-19 among Health care workers:;Demonstrate the Incidence of specific Antibodies against SARS-CoV-2 at 3 and 6 months in health care workers;Hospitalization of severe disease COVID-19;Oxygen supplementation in severe disease COVID-19;Mortality associated to progressive pulmonary disease;Need for intubation or non-invasive ventilation for the patient. |
Notes
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m. Source : ClinicalTrials.gov |
Phase 3 |
Arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "1", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "1", "treatment_id": 186, "treatment_name": "Bcg vaccine", "treatment_type": "Non covid vaccine", "pharmacological_treatment": "Non covid vaccine"}] |